|
Volumn 8, Issue 3, 1995, Pages 223-232
|
Cost Analysis of Paroxetine versus Imipramine in Major Depression
a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
IMIPRAMINE;
PAROXETINE;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DOUBLE BLIND PROCEDURE;
HEALTH CARE COST;
HUMAN;
MULTICENTER STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
ANTIDEPRESSIVE AGENTS, TRICYCLIC;
COMPUTER SIMULATION;
COSTS AND COST ANALYSIS;
DEPRESSIVE DISORDER;
HUMANS;
IMIPRAMINE;
INSURANCE, HEALTH, REIMBURSEMENT;
MODELS, ECONOMIC;
PAROXETINE;
PATIENT DROPOUTS;
RECURRENCE;
TREATMENT FAILURE;
UNITED STATES;
|
EID: 0029113495
PISSN: 11707690
EISSN: 11792027
Source Type: Journal
DOI: 10.2165/00019053-199508030-00005 Document Type: Article |
Times cited : (37)
|
References (22)
|